Downregulation of hepatic cytochrome P450 in chronic renal failure.

Chronic renal failure (CRF) is associated with a decrease in drug metabolism. The mechanism remains poorly understood. The present study investigated the repercussions of CRF on liver cytochrome P450 (CYP450). Three groups of rats were defined: control, control paired-fed, and CRF. Total CYP450 activity, protein expression of several CYP450 isoforms as well as their mRNA, and the in vitro N-demethylation of erythromycin were assessed in liver microsomes. The regulation of liver CYP450 by dexamethasone and phenobarbital was assessed in CRF rats. Compared with control and control paired-fed rats, creatinine clearance was reduced by 60% (P: < 0.01) in CRF rats. Weight was reduced by 30% (P: < 0.01) in control paired-fed and CRF rats, compared with control animals. There was no difference in the CYP450 parameters between control and control paired-fed. Compared with control paired-fed rats, total CYP450 was reduced by 47% (P: < 0.001) in CRF rats. Protein expression of CYP2C11, CYP3A1, and CYP3A2 were considerably reduced (>40%, P: < 0.001) in rats with CRF. The levels of CYP1A2, CYP2C6, CYP2D, and CYP2E1 were the same in the three groups. Northern blot analysis revealed a marked downregulation in gene expression of CYP2C11, 3A1, and 3A2 in CRF rats. Although liver CYP450 was reduced in CRF, its induction by dexamethasone and phenobarbital was present. N-demethylation of erythromycin was decreased by 50% in CRF rats compared with control (P: < 0.001). In conclusion, CRF in rats is associated with a decrease in liver cytochrome P450 activity (mainly in CYP2C11, CYP3A1, and 3A2), secondary to reduced gene expression.

[1]  A. Y. Lu,et al.  Human cytochrome P450 3A4-catalyzed testosterone 6 beta-hydroxylation and erythromycin N-demethylation. Competition during catalysis. , 1997, Drug metabolism and disposition: the biological fate of chemicals.

[2]  R. Frye,et al.  Drug Administration in Patients with Renal Insufficiency , 1997, Drug safety.

[3]  S. Massry,et al.  Abnormalities in hepatic lipase in chronic renal failure: role of excess parathyroid hormone. , 1996, The Journal of clinical investigation.

[4]  U. Hofmann,et al.  Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: Comparison of sparteine and dextromethorphan , 1996, Clinical pharmacology and therapeutics.

[5]  J. Vadgama,et al.  Impaired actions of insulin-like growth factor 1 on protein Synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect. , 1996, The Journal of clinical investigation.

[6]  E. Uchida,et al.  Changes of hepatic microsomal oxidative drug metabolizing enzymes in chronic renal failure (CRF) rats by partial nephrectomy. , 1995, Japanese journal of pharmacology.

[7]  G. Farrell,et al.  Downregulation of male‐specific cytochrome P450s 2C11 and 3A2 in bile duct–ligated male rats: Importance to reduced hepatic content of cytochrome P450 in cholestasis , 1995, Hepatology.

[8]  R. Novak,et al.  3-Methylcholanthrene and pyridine effects on CYP1A1 and CYP1A2 expression in rat renal tissue. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[9]  S. Massry,et al.  Chronic renal failure increases cytosolic Ca2+ of hepatocytes. , 1995, The American journal of physiology.

[10]  W. Graier,et al.  Cytochrome P450 mono‐oxygenase‐regulated signalling of Ca2+ entry in human and bovine endothelial cells. , 1995, The Journal of physiology.

[11]  R. Kato,et al.  Structure of a Gene and cDNA of a Major Constitutive Form of Testosterone 6β-Hydroxylase (P450/6βA) Encoding CYP3A2: Comparison of the cDNA with P450PCN2 , 1994 .

[12]  R. Talbert.  Drug Dosing in Renal Insufficiency , 1994, Journal of clinical pharmacology.

[13]  R. Feuers,et al.  Effects of caloric restriction on rodent drug and carcinogen metabolizing enzymes: implications for mutagenesis and cancer. , 1993, Mutation research.

[14]  E. Ellerbeck,et al.  Drug prescribing for patients with changing renal function. , 1992, American journal of hospital pharmacy.

[15]  R. Slaughter,et al.  The Effect of Renal Failure on Hepatic Drug Clearance , 1991, DICP : the annals of pharmacotherapy.

[16]  R. Walford,et al.  Influence of age and caloric restriction on expression of hepatic genes for xenobiotic and oxygen metabolizing enzymes in the mouse. , 1991, Journal of gerontology.

[17]  K. Konishi.  Pharmacokinetics of cefmenoxime in patients with impaired renal function and in those undergoing hemodialysis , 1986, Antimicrobial Agents and Chemotherapy.

[18]  D. Nebert,et al.  Pregnenolone 16 alpha-carbonitrile-inducible P-450 gene family: gene conversion and differential regulation , 1986, Molecular and cellular biology.

[19]  T. Gibson,et al.  Renal disease and drug metabolism: an overview. , 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  Ortiz de Montellano,et al.  Cytochrome P-450: Structure, Mechanism, and Biochemistry , 1986 .

[21]  Y. Ozawa,et al.  Pharmacokinetics of cefotiam in patients with impaired renal function and in those undergoing hemodialysis , 1984, Antimicrobial Agents and Chemotherapy.

[22]  V. H. Cohn,et al.  Hepatic drug metabolism in rats with experimental chronic renal failure. , 1984, Biochemical pharmacology.

[23]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Schütterle,et al.  Enzyme induction in the uremic liver. , 1978, Kidney international. Supplement.

[25]  Belpaire Fm,et al.  Hepatic oxidative drug metabolism in rats with experimental renal failure. , 1977 .

[26]  D. L. Cinti,et al.  Kinetic parameters of drug-metabolizing enzymes in Ca 2+ -sedimented microsomes from rat liver. , 1972, Biochemical pharmacology.

[27]  G. Schütterle,et al.  Oxidative drug metabolism in liver microsomes from uremic rats. , 1972, Kidney international.

[28]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[29]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[30]  T NASH,et al.  The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. , 1953, The Biochemical journal.

[31]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[32]  R. Talbert,et al.  Principles of Drug Administration in Renal Insufficiency , 1997, Clinical pharmacokinetics.

[33]  P. White,et al.  Calcium regulates human CYP11B2 transcription. , 1996, Endocrine research.

[34]  R. Kato,et al.  Structure of a gene and cDNA of a major constitutive form of testosterone 6 beta-hydroxylase (P450/6 beta A) encoding CYP3A2: comparison of the cDNA with P450PCN2. , 1994, Archives of biochemistry and biophysics.

[35]  S. Massry,et al.  Chronic renal failure is a state of cellular calcium toxicity. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  S. Wrighton,et al.  The human hepatic cytochromes P450 involved in drug metabolism. , 1992, Critical reviews in toxicology.

[37]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. , 1992, Biotechnology.

[38]  F. Belpaire,et al.  Hepatic oxidative drug metabolism in rats with experimental renal failure. , 1977, Archives internationales de pharmacodynamie et de therapie.